What does PHARMACIE SIXTINE BRUNELLI do?

PHARMACIE SIXTINE BRUNELLI is a pharmacy in Braine-l'Alleud. Private Limited, started on 4 July 2019, 1 establishment.

What is the address of PHARMACIE SIXTINE BRUNELLI?

The registered office of PHARMACIE SIXTINE BRUNELLI is located at Av des 20 Bonniers 54, 1421 Braine-l'Alleud.

Is PHARMACIE SIXTINE BRUNELLI still active?

Yes. According to the CBE (18 September 2026) PHARMACIE SIXTINE BRUNELLI is active, legal situation “Normale toestand”, started on 4 July 2019.

Is PHARMACIE SIXTINE BRUNELLI registered on Peppol?

Yes, PHARMACIE SIXTINE BRUNELLI is registered on the Peppol network with ID 0208:0729811172.

What is the enterprise number of PHARMACIE SIXTINE BRUNELLI?

The enterprise number of PHARMACIE SIXTINE BRUNELLI is BE0729811172.

When was PHARMACIE SIXTINE BRUNELLI founded?

PHARMACIE SIXTINE BRUNELLI was founded on 4 July 2019.

Who are the directors of PHARMACIE SIXTINE BRUNELLI?

According to the 2025 annual accounts, the directors of PHARMACIE SIXTINE BRUNELLI are: SIXTINE BRUNELLI.

Is PHARMACIE SIXTINE BRUNELLI a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 July 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE SIXTINE BRUNELLI make in 2025?

PHARMACIE SIXTINE BRUNELLI posted a profit after taxes of € 28,198 in financial year 2025.

What is the revenue of PHARMACIE SIXTINE BRUNELLI?

As a small company, PHARMACIE SIXTINE BRUNELLI is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 46,164.

PHARMACIE SIXTINE BRUNELLI (Private Limited)

Dossier PHARMACIE SIXTINE BRUNELLI, printed on 18 September 2026 from databakkes.be/en/0729811172/pharmacie-sixtine-brunelli. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 48 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE SIXTINE BRUNELLI from Braine-l'Alleud, company number BE0729811172, closed financial year 2025 with a result of € 28,198 after tax. For that financial year PHARMACIE SIXTINE BRUNELLI recorded a gross margin of € 46,164 and equity of € 327,726. Compared with financial year 2024, the result moved from € 28,105 to € 28,198. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 327,726

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 28,198

Profit after tax over the fiscal year.

Cash in the bank

€ 2,987

▲ 69% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 302,726.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 190,142

▼ 21% vs 2024

€ 51,054 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 2,731

▲ 28% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,131

▼ 66% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 108,727 Gross margin 2022: € 108,727 First fiscal year in the series	€ 90,927 Gross margin 2023: € 90,927 ▼ 16% vs 2022 (€ 108,727) Unfavourable step	€ 48,926 Gross margin 2024: € 48,926 ▼ 46% vs 2023 (€ 90,927) Unfavourable step	€ 46,164 Gross margin 2025: € 46,164 ▼ 6% vs 2024 (€ 48,926) Unfavourable step	▼ 6%
Profit after taxes	€ 81,573 Profit after taxes 2022: € 81,573 First fiscal year in the series	€ 67,075 Profit after taxes 2023: € 67,075 ▼ 18% vs 2022 (€ 81,573) Unfavourable step	€ 28,105 Profit after taxes 2024: € 28,105 ▼ 58% vs 2023 (€ 67,075) Unfavourable step	€ 28,198 Profit after taxes 2025: € 28,198 Unchanged (€ 28,105) Favourable step
Equity	€ 204,348 Equity 2022: € 204,348 First fiscal year in the series	€ 271,423 Equity 2023: € 271,423 ▲ 33% vs 2022 (€ 204,348) Favourable step	€ 299,528 Equity 2024: € 299,528 ▲ 10% vs 2023 (€ 271,423) Favourable step	€ 327,726 Equity 2025: € 327,726 ▲ 9% vs 2024 (€ 299,528) Favourable step	▲ 9%
Total debts	€ 412,276 Total debts 2022: € 412,276 First fiscal year in the series	€ 414,283 Total debts 2023: € 414,283 Unchanged (€ 412,276) Unfavourable step	€ 367,743 Total debts 2024: € 367,743 ▼ 11% vs 2023 (€ 414,283) Favourable step	€ 298,471 Total debts 2025: € 298,471 ▼ 19% vs 2024 (€ 367,743) Favourable step	▼ 19%
Cash	€ 4,690 Cash 2022: € 4,690 First fiscal year in the series	€ 3,452 Cash 2023: € 3,452 ▼ 26% vs 2022 (€ 4,690) Unfavourable step	€ 1,770 Cash 2024: € 1,770 ▼ 49% vs 2023 (€ 3,452) Unfavourable step	€ 2,987 Cash 2025: € 2,987 ▲ 69% vs 2024 (€ 1,770) Favourable step	▲ 69%
Retained profit	€ 179,348 Retained profit 2022: € 179,348 First fiscal year in the series	€ 246,423 Retained profit 2023: € 246,423 ▲ 37% vs 2022 (€ 179,348) Favourable step	€ 274,528 Retained profit 2024: € 274,528 ▲ 11% vs 2023 (€ 246,423) Favourable step	€ 302,726 Retained profit 2025: € 302,726 ▲ 10% vs 2024 (€ 274,528) Favourable step	▲ 10%
Dividend	€ 50,000 Dividend 2022: € 50,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 50,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 347,135 Bank debt 2022: € 347,135 First fiscal year in the series	€ 297,906 Bank debt 2023: € 297,906 ▼ 14% vs 2022 (€ 347,135) Favourable step	€ 240,605 Bank debt 2024: € 240,605 ▼ 19% vs 2023 (€ 297,906) Favourable step	€ 190,142 Bank debt 2025: € 190,142 ▼ 21% vs 2024 (€ 240,605) Favourable step	▼ 21%
Balance sheet total	€ 616,624 Balance sheet total 2022: € 616,624 First fiscal year in the series	€ 685,706 Balance sheet total 2023: € 685,706 ▲ 11% vs 2022 (€ 616,624) Unchanged	€ 667,270 Balance sheet total 2024: € 667,270 ▼ 3% vs 2023 (€ 685,706) Unchanged	€ 626,197 Balance sheet total 2025: € 626,197 ▼ 6% vs 2024 (€ 667,270) Unchanged	▼ 6%

Key figures of PHARMACIE SIXTINE BRUNELLI, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE SIXTINE BRUNELLI?

What happened at PHARMACIE SIXTINE BRUNELLI in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 28,198. Source: NBB ↗
Sep 1, 2019 New establishment in Sint-Pieters-Woluwe. KBO
2019 SIXTINE BRUNELLI became a director. NBB
Jul 4, 2019 Start of the company according to the CBE. KBO

In short

From € 81,573 profit in 2022 to € 28,198 profit in 2025.

Paid € 56,279 in corporate taxes since 2022.

Best year ever: 2022, with € 81,573 profit.

Paid out € 50,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE SIXTINE BRUNELLI? We notify you, reason included.

Follow PHARMACIE SIXTINE BRUNELLI

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

SIXTINE BRUNELLI

PHARMACIE SIXTINE BRUNELLI

PHARMACIE ORBAN 100%

Behind PHARMACIE SIXTINE BRUNELLI is SIXTINE BRUNELLI. It owns 100% of PHARMACIE ORBAN itself.

See the full network in the app

Directors

According to the 2025 annual accounts

SIXTINE BRUNELLI

Director

Also active at: PHARMACIE ORBAN

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Av des 20 Bonniers 54

1421 Braine-l'Alleud

2.291.214.531

Orbanlaan 4

1150 Sint-Pieters-Woluwe

Active since 1 September 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0729.811.172

VAT number

BE 0729.811.172

Registered office

Av des 20 Bonniers 54, 1421 Braine-l'Alleud

Names & denominations

PHARMACIE SIXTINE BRUNELLI

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

4 July 2019

Peppol

Active · Active since 26 Nov 2025

Contact

[email protected]

Activities · NACE

Detailhandel in farmaceutische producten

Markt- en opinieonderzoek

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE SIXTINE BRUNELLI

Warning lights

Financials

What happened to PHARMACIE SIXTINE BRUNELLI?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions